Christina Rautenberg
8PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 16, 2025
Multicenter validation of the newly developed Concise Objectifiable Risk Evaluation (CORE) score also confirms its ability to complement the Hematopoietic Cell Comorbidity Index (HCT-CI).Gunnar Weise, Christina Rautenberg, Alexander Denk
|Sep 09, 2025
Outcome after Treosulfan-based conditioning in a real-world MDS cohort.Christina Rautenberg, Jacob Pyka, Tim Lohmann
|Aug 19, 2025
Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party.Drazen Pulanic, Christophe Peczynski, William Boreland
|Mar 22, 2024
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study.Ali Bazarbachi, Myriam Labopin, Nour Moukalled
|May 14, 2021
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS.Christina Rautenberg, Michael Lauseker, Jennifer Kaivers
|Oct 05, 2020
Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia.Christina Rautenberg, Ulrich Germing, Stefanie Stepanow
Pageof 2
Frequent Collaborators
2 joint publications
Michael Lauseker
2 joint publications
Nicolaus Kröger
2 joint publications
Didier Blaise
1 joint publications
Thomas Schroeder
1 joint publications
Jennifer Kaivers
1 joint publications
Ali Bazarbachi
1 joint publications
Myriam Labopin
1 joint publications
Nour Moukalled
1 joint publications
Johannes Schetelig
1 joint publications
Jürgen Finke
